20-F Filing

COLLPLANT BIOTECHNOLOGIES LTD CIK: 1631487 FY 2018

Filing Information

Form Type	20-F
Accession Number	`0001213900-19-005360`
Period End Date	20181231
Filing Date	20190401
Fiscal Year	2018
Fiscal Period	FY
XBRL Instance	clgn-20181231.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 100 Income Statement 55 Cash Flow Statement 138 Stockholders Equity 35

Balance Sheet 100 line items

Line Item	Tag	Value	Unit	Period
Cash and cash equivalents	`CashAndCashEquivalents`	20.07M	ILS	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalents`	$5.35M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalents`	5.32M	ILS	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalents`	3.80M	ILS	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalents`	$4.75M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalents`	17.82M	ILS	Point-in-time
Trade receivables	`TradeReceivables`	$516.00K	USD	Point-in-time
Trade receivables	`TradeReceivables`	1.93M	ILS	Point-in-time
Trade receivables	`TradeReceivables`	354,000.00	ILS	Point-in-time
Other	`OtherCurrentReceivables`	3.54M	ILS	Point-in-time
Other	`OtherCurrentReceivables`	$334.00K	USD	Point-in-time
Other	`OtherCurrentReceivables`	1.25M	ILS	Point-in-time
Restricted deposit	`CurrentAssetsRestrictedDeposit`	584,000.00	ILS	Point-in-time
Restricted deposit	`CurrentAssetsRestrictedDeposit`	-	ILS	Point-in-time
Restricted deposit	`CurrentAssetsRestrictedDeposit`	$154.00K	USD	Point-in-time
Inventory	`Inventories`	3.05M	ILS	Point-in-time
Inventory	`Inventories`	$814.00K	USD	Point-in-time
Inventory	`Inventories`	700,000.00	ILS	Point-in-time
Total current assets	`CurrentAssets`	22.41M	ILS	Point-in-time
Total current assets	`CurrentAssets`	$7.17M	USD	Point-in-time
Total current assets	`CurrentAssets`	26.89M	ILS	Point-in-time
Restricted deposit	`NoncurrentAssetsRestrictedDeposit`	$155.00K	USD	Point-in-time
Restricted deposit	`NoncurrentAssetsRestrictedDeposit`	503,000.00	ILS	Point-in-time
Restricted deposit	`NoncurrentAssetsRestrictedDeposit`	580,000.00	ILS	Point-in-time
Long term-receivables	`NoncurrentAssetsLongTermReceivables`	68,000.00	ILS	Point-in-time
Long term-receivables	`NoncurrentAssetsLongTermReceivables`	92,000.00	ILS	Point-in-time
Long term-receivables	`NoncurrentAssetsLongTermReceivables`	$18.00K	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipment`	4.01M	ILS	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipment`	5.27M	ILS	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipment`	3.58M	ILS	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipment`	$1.41M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsAndGoodwill`	$340.00K	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsAndGoodwill`	1.45M	ILS	Point-in-time
Intangible assets, net	`IntangibleAssetsAndGoodwill`	1.27M	ILS	Point-in-time
Total non-current assets	`NoncurrentAssets`	5.63M	ILS	Point-in-time
Total non-current assets	`NoncurrentAssets`	7.20M	ILS	Point-in-time
Total non-current assets	`NoncurrentAssets`	$1.92M	USD	Point-in-time
Total assets	`Assets`	28.05M	ILS	Point-in-time
Total assets	`Assets`	$9.09M	USD	Point-in-time
Total assets	`Assets`	34.08M	ILS	Point-in-time
Loan	`LongTermLoanCurrent`	84,000.00	ILS	Point-in-time
Loan	`LongTermLoanCurrent`	-	ILS	Point-in-time
Loan	`LongTermLoanCurrent`	$22.00K	USD	Point-in-time
Trade payables	`TradeAndOtherCurrentPayablesToTradeSuppliers`	2.92M	ILS	Point-in-time
Trade payables	`TradeAndOtherCurrentPayablesToTradeSuppliers`	$622.00K	USD	Point-in-time
Trade payables	`TradeAndOtherCurrentPayablesToTradeSuppliers`	2.33M	ILS	Point-in-time
Accrued liabilities and other	`OtherCurrentPayables`	2.37M	ILS	Point-in-time
Accrued liabilities and other	`OtherCurrentPayables`	$631.00K	USD	Point-in-time
Accrued liabilities and other	`OtherCurrentPayables`	2.00M	ILS	Point-in-time
Contract liabilities	`CurrentContractLiabilities`	3.64M	ILS	Point-in-time
Contract liabilities	`CurrentContractLiabilities`	$970.00K	USD	Point-in-time
Contract liabilities	`CurrentContractLiabilities`	-	ILS	Point-in-time
Total current liabilities	`CurrentLiabilities`	8.42M	ILS	Point-in-time
Total current liabilities	`CurrentLiabilities`	4.92M	ILS	Point-in-time
Total current liabilities	`CurrentLiabilities`	$2.25M	USD	Point-in-time
Debentures at fair value	`NoncurrentFinancialLiabilities`	12.64M	ILS	Point-in-time
Warrants at fair value	`WarrantsAtFairValue`	2.43M	ILS	Point-in-time
Warrants at fair value	`WarrantsAtFairValue`	$649.00K	USD	Point-in-time
Derivatives	`NoncurrentDebtInstrumentsIssued`	363,000.00	ILS	Point-in-time
Derivatives	`NoncurrentDebtInstrumentsIssued`	141,000.00	ILS	Point-in-time
Derivatives	`NoncurrentDebtInstrumentsIssued`	$97.00K	USD	Point-in-time
Royalties to the Israel Innovation Authority	`RoyaltiesToIsraelInnovationAuthority`	1.20M	ILS	Point-in-time
Royalties to the Israel Innovation Authority	`RoyaltiesToIsraelInnovationAuthority`	1.19M	ILS	Point-in-time
Royalties to the Israel Innovation Authority	`RoyaltiesToIsraelInnovationAuthority`	$316.00K	USD	Point-in-time
Loan	`LongTermLoanNonCurrent`	84,000.00	ILS	Point-in-time
Loan	`LongTermLoanNonCurrent`	$22.00K	USD	Point-in-time
Loan	`LongTermLoanNonCurrent`	-	ILS	Point-in-time
Long term contract liabilities	`NoncurrentContractLiabilities`	$980.00K	USD	Point-in-time
Long term contract liabilities	`NoncurrentContractLiabilities`	-	ILS	Point-in-time
Long term contract liabilities	`NoncurrentContractLiabilities`	3.67M	ILS	Point-in-time
Long-term payables	`LongTermPayables`	-	ILS	Point-in-time
Long-term payables	`LongTermPayables`	-	USD	Point-in-time
Long-term payables	`LongTermPayables`	61,000.00	ILS	Point-in-time
Total non-current liabilities	`NoncurrentLiabilities`	14.04M	ILS	Point-in-time
Total non-current liabilities	`NoncurrentLiabilities`	7.74M	ILS	Point-in-time
Total non-current liabilities	`NoncurrentLiabilities`	$2.06M	USD	Point-in-time
Commitments and contingent liabilities	`CommitmentsAndContingentLiabilities`	-	USD	Point-in-time
Commitments and contingent liabilities	`CommitmentsAndContingentLiabilities`	-	ILS	Point-in-time
Commitments and contingent liabilities	`CommitmentsAndContingentLiabilities`	-	ILS	Point-in-time
Total liabilities	`Liabilities`	$4.31M	USD	Point-in-time
Total liabilities	`Liabilities`	18.96M	ILS	Point-in-time
Total liabilities	`Liabilities`	16.16M	ILS	Point-in-time
Ordinary shares	`OrdinaryShares`	$1.52M	USD	Point-in-time
Ordinary shares	`OrdinaryShares`	5.72M	ILS	Point-in-time
Ordinary shares	`OrdinaryShares`	5.00M	ILS	Point-in-time
Additional paid in capital and warrants	`AdditionalPaidinCapital`	178.47M	ILS	Point-in-time
Additional paid in capital and warrants	`AdditionalPaidinCapital`	196.87M	ILS	Point-in-time
Additional paid in capital and warrants	`AdditionalPaidinCapital`	$52.53M	USD	Point-in-time
Accumulated deficit	`RetainedEarnings`	-174.38M	ILS	Point-in-time
Accumulated deficit	`RetainedEarnings`	$-49.27M	USD	Point-in-time
Accumulated deficit	`RetainedEarnings`	-184.66M	ILS	Point-in-time
Total equity	`Equity`	$4.78M	USD	Point-in-time
Total equity	`Equity`	9.78M	ILS	Point-in-time
Total equity	`Equity`	17.93M	ILS	Point-in-time
Total equity	`Equity`	9.08M	ILS	Point-in-time
Total equity	`Equity`	$2.42M	USD	Point-in-time
Total equity	`Equity`	5.16M	ILS	Point-in-time
Total liabilities and equity	`EquityAndLiabilities`	$9.09M	USD	Point-in-time
Total liabilities and equity	`EquityAndLiabilities`	34.08M	ILS	Point-in-time
Total liabilities and equity	`EquityAndLiabilities`	28.05M	ILS	Point-in-time

Income Statement 55 line items

Line Item	Tag	Value	Unit	Period
Revenue	`Revenue`	292,000.00	ILS	Annual
Revenue	`Revenue`	18.03M	ILS	Annual
Revenue	`Revenue`	$4.81M	USD	Annual
Revenue	`Revenue`	1.67M	ILS	Annual
Cost of revenue	`CostOfSales`	1.43M	ILS	Annual
Cost of revenue	`CostOfSales`	52,000.00	ILS	Annual
Cost of revenue	`CostOfSales`	$380.00K	USD	Annual
Cost of revenue	`CostOfSales`	-	ILS	Annual
Gross profit	`GrossProfit`	292,000.00	ILS	Annual
Gross profit	`GrossProfit`	$4.43M	USD	Annual
Gross profit	`GrossProfit`	1.62M	ILS	Annual
Gross profit	`GrossProfit`	16.61M	ILS	Annual
Research and development expenses	`ResearchAndDevelopmentExpense`	16.21M	ILS	Annual
Research and development expenses	`ResearchAndDevelopmentExpense`	29.20M	ILS	Annual
Research and development expenses	`ResearchAndDevelopmentExpense`	16.92M	ILS	Annual
Research and development expenses	`ResearchAndDevelopmentExpense`	$4.33M	USD	Annual
Participation in research and development expenses, net	`TransfersOfResearchAndDevelopmentFromEntityRelatedPartyTransactions`	-12.41M	ILS	Annual
Participation in research and development expenses, net	`TransfersOfResearchAndDevelopmentFromEntityRelatedPartyTransactions`	3.23M	ILS	Annual
Participation in research and development expenses, net	`TransfersOfResearchAndDevelopmentFromEntityRelatedPartyTransactions`	-2.85M	ILS	Annual
Participation in research and development expenses, net	`TransfersOfResearchAndDevelopmentFromEntityRelatedPartyTransactions`	$861.00K	USD	Annual
Research and development expenses, net	`ResearchAndDevelopmentExpenseNet`	19.44M	ILS	Annual
Research and development expenses, net	`ResearchAndDevelopmentExpenseNet`	14.07M	ILS	Annual
Research and development expenses, net	`ResearchAndDevelopmentExpenseNet`	16.79M	ILS	Annual
Research and development expenses, net	`ResearchAndDevelopmentExpenseNet`	$5.19M	USD	Annual
General, administrative and marketing expenses	`SellingGeneralAndAdministrativeExpense`	11.05M	ILS	Annual
General, administrative and marketing expenses	`SellingGeneralAndAdministrativeExpense`	8.30M	ILS	Annual
General, administrative and marketing expenses	`SellingGeneralAndAdministrativeExpense`	12.48M	ILS	Annual
General, administrative and marketing expenses	`SellingGeneralAndAdministrativeExpense`	$3.33M	USD	Annual
Operating loss	`ProfitLossFromOperatingActivities`	-15.31M	ILS	Annual
Operating loss	`ProfitLossFromOperatingActivities`	$-4.08M	USD	Annual
Operating loss	`ProfitLossFromOperatingActivities`	-27.55M	ILS	Annual
Operating loss	`ProfitLossFromOperatingActivities`	-20.75M	ILS	Annual
Financial income	`FinanceIncome`	1.65M	ILS	Annual
Financial income	`FinanceIncome`	$440.00K	USD	Annual
Financial income	`FinanceIncome`	253,000.00	ILS	Annual
Financial income	`FinanceIncome`	93,000.00	ILS	Annual
Financial expenses	`FinanceCosts`	225,000.00	ILS	Annual
Financial expenses	`FinanceCosts`	380,000.00	ILS	Annual
Financial expenses	`FinanceCosts`	441,000.00	ILS	Annual
Financial expenses	`FinanceCosts`	$60.00K	USD	Annual
Financial income (expenses), net	`FinanceIncomeCost`	-348,000.00	ILS	Annual
Financial income (expenses), net	`FinanceIncomeCost`	$380.00K	USD	Annual
Financial income (expenses), net	`FinanceIncomeCost`	1.43M	ILS	Annual
Financial income (expenses), net	`FinanceIncomeCost`	-127,000.00	ILS	Annual
Comprehensive loss	`ComprehensiveIncome`	-13.89M	ILS	Annual
Comprehensive loss	`ComprehensiveIncome`	-27.89M	ILS	Annual
Comprehensive loss	`ComprehensiveIncome`	-20.88M	ILS	Annual
Comprehensive loss	`ComprehensiveIncome`	$-3.70M	USD	Annual
Basic and diluted loss per ordinary share (NIS/USD)	`BasicAndDilutedEarningsLossPerShare`	0.06	ILS	Annual
Basic and diluted loss per ordinary share (NIS/USD)	`BasicAndDilutedEarningsLossPerShare`	0.16	ILS	Annual
Basic and diluted loss per ordinary share (NIS/USD)	`BasicAndDilutedEarningsLossPerShare`	0.28	ILS	Annual
Basic and diluted loss per ordinary share (NIS/USD)	`BasicAndDilutedEarningsLossPerShare`	$0.02	USD	Annual
Weighted average ordinary shares outstanding	`WeightedAverageShares`	133.19M	shares	Annual
Weighted average ordinary shares outstanding	`WeightedAverageShares`	219.23M	shares	Annual
Weighted average ordinary shares outstanding	`WeightedAverageShares`	100.62M	shares	Annual

Cash Flow Statement 138 line items

Line Item	Tag	Value	Unit	Period
Net cash used in operations (see Appendix A)	`CashFlowsFromUsedInOperations`	-4.67M	ILS	Annual
Net cash used in operations (see Appendix A)	`CashFlowsFromUsedInOperations`	-17.88M	ILS	Annual
Net cash used in operations (see Appendix A)	`CashFlowsFromUsedInOperations`	-19.36M	ILS	Annual
Net cash used in operations (see Appendix A)	`CashFlowsFromUsedInOperations`	$-1.25M	USD	Annual
Net cash used in operating activities	`CashFlowsFromUsedInOperatingActivities`	$-1.25M	USD	Annual
Net cash used in operating activities	`CashFlowsFromUsedInOperatingActivities`	-17.88M	ILS	Annual
Net cash used in operating activities	`CashFlowsFromUsedInOperatingActivities`	-19.36M	ILS	Annual
Net cash used in operating activities	`CashFlowsFromUsedInOperatingActivities`	-4.67M	ILS	Annual
Restricted deposits	`ResrictedDepositsClassifiedAsInvestingActivities`	-	ILS	Annual
Restricted deposits	`ResrictedDepositsClassifiedAsInvestingActivities`	-620,000.00	ILS	Annual
Restricted deposits	`ResrictedDepositsClassifiedAsInvestingActivities`	-	ILS	Annual
Restricted deposits	`ResrictedDepositsClassifiedAsInvestingActivities`	$-166.00K	USD	Annual
Purchase of property and equipment	`PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities`	2.98M	ILS	Annual
Purchase of property and equipment	`PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities`	447,000.00	ILS	Annual
Purchase of property and equipment	`PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities`	492,000.00	ILS	Annual
Purchase of property and equipment	`PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities`	$796.00K	USD	Annual
Net cash used in investing activities	`CashFlowsFromUsedInInvestingActivities`	-492,000.00	ILS	Annual
Net cash used in investing activities	`CashFlowsFromUsedInInvestingActivities`	-3.60M	ILS	Annual
Net cash used in investing activities	`CashFlowsFromUsedInInvestingActivities`	-447,000.00	ILS	Annual
Net cash used in investing activities	`CashFlowsFromUsedInInvestingActivities`	$-962.00K	USD	Annual
Proceeds from issuance of shares, warrants and debentures, less issuance expenses	`ProceedsFromIssuingShares`	10.00M	ILS	Annual
Proceeds from issuance of shares, warrants and debentures, less issuance expenses	`ProceedsFromIssuingShares`	18.50M	ILS	Annual
Proceeds from issuance of shares, warrants and debentures, less issuance expenses	`ProceedsFromIssuingShares`	29.03M	ILS	Annual
Proceeds from issuance of shares, warrants and debentures, less issuance expenses	`ProceedsFromIssuingShares`	$2.67M	USD	Annual
Exercise of options and warrants into shares	`ProceedsFromExerciseOfOptions`	-	ILS	Annual
Exercise of options and warrants into shares	`ProceedsFromExerciseOfOptions`	3.62M	ILS	Annual
Exercise of options and warrants into shares	`ProceedsFromExerciseOfOptions`	-	USD	Annual
Exercise of options and warrants into shares	`ProceedsFromExerciseOfOptions`	-	ILS	Annual
Loan received	`ProceedsFromBorrowingsClassifiedAsFinancingActivities`	210,000.00	ILS	Annual
Loan received	`ProceedsFromBorrowingsClassifiedAsFinancingActivities`	-	ILS	Annual
Loan received	`ProceedsFromBorrowingsClassifiedAsFinancingActivities`	$57.00K	USD	Annual
Loan received	`ProceedsFromBorrowingsClassifiedAsFinancingActivities`	-	ILS	Annual
Loan paid	`RepaymentsOfBorrowingsClassifiedAsFinancingActivities`	-	ILS	Annual
Loan paid	`RepaymentsOfBorrowingsClassifiedAsFinancingActivities`	42,000.00	ILS	Annual
Loan paid	`RepaymentsOfBorrowingsClassifiedAsFinancingActivities`	$11.00K	USD	Annual
Loan paid	`RepaymentsOfBorrowingsClassifiedAsFinancingActivities`	-	ILS	Annual
Payments made for equipment on financing terms	`RepaymentsOfNoncurrentBorrowings`	253,000.00	ILS	Annual
Payments made for equipment on financing terms	`RepaymentsOfNoncurrentBorrowings`	$67.00K	USD	Annual
Payments made for equipment on financing terms	`RepaymentsOfNoncurrentBorrowings`	252,000.00	ILS	Annual
Payments made for equipment on financing terms	`RepaymentsOfNoncurrentBorrowings`	19,000.00	ILS	Annual
Net cash provided by financing activities	`CashFlowsFromUsedInFinancingActivities`	32.40M	ILS	Annual
Net cash provided by financing activities	`CashFlowsFromUsedInFinancingActivities`	$2.65M	USD	Annual
Net cash provided by financing activities	`CashFlowsFromUsedInFinancingActivities`	18.49M	ILS	Annual
Net cash provided by financing activities	`CashFlowsFromUsedInFinancingActivities`	9.91M	ILS	Annual
Increase (Decrease) in cash and cash equivalents	`IncreaseDecreaseInCashAndCashEquivalents`	-1.36M	ILS	Annual
Increase (Decrease) in cash and cash equivalents	`IncreaseDecreaseInCashAndCashEquivalents`	14.06M	ILS	Annual
Increase (Decrease) in cash and cash equivalents	`IncreaseDecreaseInCashAndCashEquivalents`	1.65M	ILS	Annual
Increase (Decrease) in cash and cash equivalents	`IncreaseDecreaseInCashAndCashEquivalents`	$440.00K	USD	Annual
Cash and cash equivalents at the beginning of the year	`CashAndCashEquivalents`	$4.75M	USD	Point-in-time
Cash and cash equivalents at the beginning of the year	`CashAndCashEquivalents`	17.82M	ILS	Point-in-time
Cash and cash equivalents at the beginning of the year	`CashAndCashEquivalents`	3.80M	ILS	Point-in-time
Cash and cash equivalents at the beginning of the year	`CashAndCashEquivalents`	5.32M	ILS	Point-in-time
Cash and cash equivalents at the beginning of the year	`CashAndCashEquivalents`	$5.35M	USD	Point-in-time
Cash and cash equivalents at the beginning of the year	`CashAndCashEquivalents`	20.07M	ILS	Point-in-time
Exchange differences on cash and cash equivalents	`EffectOfExchangeRateChangesOnCashAndCashEquivalents`	601,000.00	ILS	Annual
Exchange differences on cash and cash equivalents	`EffectOfExchangeRateChangesOnCashAndCashEquivalents`	$160.00K	USD	Annual
Exchange differences on cash and cash equivalents	`EffectOfExchangeRateChangesOnCashAndCashEquivalents`	-157,000.00	ILS	Annual
Exchange differences on cash and cash equivalents	`EffectOfExchangeRateChangesOnCashAndCashEquivalents`	-44,000.00	ILS	Annual
Cash and cash equivalents at the end of the year	`CashAndCashEquivalents`	20.07M	ILS	Point-in-time
Cash and cash equivalents at the end of the year	`CashAndCashEquivalents`	$5.35M	USD	Point-in-time
Cash and cash equivalents at the end of the year	`CashAndCashEquivalents`	5.32M	ILS	Point-in-time
Cash and cash equivalents at the end of the year	`CashAndCashEquivalents`	3.80M	ILS	Point-in-time
Cash and cash equivalents at the end of the year	`CashAndCashEquivalents`	$4.75M	USD	Point-in-time
Cash and cash equivalents at the end of the year	`CashAndCashEquivalents`	17.82M	ILS	Point-in-time
Comprehensive loss for the year	`ComprehensiveIncome`	-13.89M	ILS	Annual
Comprehensive loss for the year	`ComprehensiveIncome`	-27.89M	ILS	Annual
Comprehensive loss for the year	`ComprehensiveIncome`	-20.88M	ILS	Annual
Comprehensive loss for the year	`ComprehensiveIncome`	$-3.70M	USD	Annual
Depreciation and amortization	`AdjustmentsForDepreciationAndAmortisationExpense`	$392.00K	USD	Annual
Depreciation and amortization	`AdjustmentsForDepreciationAndAmortisationExpense`	1.47M	ILS	Annual
Depreciation and amortization	`AdjustmentsForDepreciationAndAmortisationExpense`	864,000.00	ILS	Annual
Depreciation and amortization	`AdjustmentsForDepreciationAndAmortisationExpense`	1.05M	ILS	Annual
Share-based compensation to employees and consultants	`AdjustmentsForSharebasedPayments`	3.57M	ILS	Annual
Share-based compensation to employees and consultants	`AdjustmentsForSharebasedPayments`	$1.38M	USD	Annual
Share-based compensation to employees and consultants	`AdjustmentsForSharebasedPayments`	5.17M	ILS	Annual
Share-based compensation to employees and consultants	`AdjustmentsForSharebasedPayments`	4.97M	ILS	Annual
Exchange differences on cash and cash equivalents	`EffectOfExchangeRateChangesOnCashAndCashEquivalent`	$-160.00K	USD	Annual
Exchange differences on cash and cash equivalents	`EffectOfExchangeRateChangesOnCashAndCashEquivalent`	44,000.00	ILS	Annual
Exchange differences on cash and cash equivalents	`EffectOfExchangeRateChangesOnCashAndCashEquivalent`	-601,000.00	ILS	Annual
Exchange differences on cash and cash equivalents	`EffectOfExchangeRateChangesOnCashAndCashEquivalent`	157,000.00	ILS	Annual
Changes in fair value of financial instruments	`AdjustmentsForIncreaseDecreaseInDerivativeFinancialLiabilities`	-35,000.00	ILS	Annual
Changes in fair value of financial instruments	`AdjustmentsForIncreaseDecreaseInDerivativeFinancialLiabilities`	-891,000.00	ILS	Annual
Changes in fair value of financial instruments	`AdjustmentsForIncreaseDecreaseInDerivativeFinancialLiabilities`	-	ILS	Annual
Changes in fair value of financial instruments	`AdjustmentsForIncreaseDecreaseInDerivativeFinancialLiabilities`	$-238.00K	USD	Annual
Exchange differences on restricted deposit	`EffectOfExchangeRateChangesOnRestrictedCash`	$-11.00K	USD	Annual
Exchange differences on restricted deposit	`EffectOfExchangeRateChangesOnRestrictedCash`	8,000.00	ILS	Annual
Exchange differences on restricted deposit	`EffectOfExchangeRateChangesOnRestrictedCash`	54,000.00	ILS	Annual
Exchange differences on restricted deposit	`EffectOfExchangeRateChangesOnRestrictedCash`	-41,000.00	ILS	Annual
Total net cash used in operations	`CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital`	-8.78M	ILS	Annual
Total net cash used in operations	`CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital`	$-2.34M	USD	Annual
Total net cash used in operations	`CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital`	-23.29M	ILS	Annual
Total net cash used in operations	`CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital`	-14.80M	ILS	Annual
Increase in trade receivables	`AdjustmentsForDecreaseIncreaseInTradeAccountReceivable`	-544,000.00	ILS	Annual
Increase in trade receivables	`AdjustmentsForDecreaseIncreaseInTradeAccountReceivable`	-1.58M	ILS	Annual
Increase in trade receivables	`AdjustmentsForDecreaseIncreaseInTradeAccountReceivable`	$-421.00K	USD	Annual
Increase in trade receivables	`AdjustmentsForDecreaseIncreaseInTradeAccountReceivable`	-137,000.00	ILS	Annual
Increase in inventory	`AdjustmentsForDecreaseIncreaseInInventories`	-213,000.00	ILS	Annual
Increase in inventory	`AdjustmentsForDecreaseIncreaseInInventories`	-487,000.00	ILS	Annual
Increase in inventory	`AdjustmentsForDecreaseIncreaseInInventories`	-2.35M	ILS	Annual
Increase in inventory	`AdjustmentsForDecreaseIncreaseInInventories`	$-628.00K	USD	Annual
Decrease (increase) in other receivables (including long-term receivables)	`AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables`	$209.00K	USD	Annual
Decrease (increase) in other receivables (including long-term receivables)	`AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables`	-95,000.00	ILS	Annual
Decrease (increase) in other receivables (including long-term receivables)	`AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables`	101,000.00	ILS	Annual
Decrease (increase) in other receivables (including long-term receivables)	`AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables`	784,000.00	ILS	Annual
Increase (decrease) in trade payables (including long-term payables)	`AdjustmentForIncreaseInLongTermPayables`	2.50M	ILS	Annual
Increase (decrease) in trade payables (including long-term payables)	`AdjustmentForIncreaseInLongTermPayables`	-2.24M	ILS	Annual
Increase (decrease) in trade payables (including long-term payables)	`AdjustmentForIncreaseInLongTermPayables`	-400,000.00	ILS	Annual
Increase (decrease) in trade payables (including long-term payables)	`AdjustmentForIncreaseInLongTermPayables`	$-107.00K	USD	Annual
Increase in accrued liabilities and other payables	`AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables`	370,000.00	ILS	Annual
Increase in accrued liabilities and other payables	`AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables`	382,000.00	ILS	Annual
Increase in accrued liabilities and other payables	`AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables`	379,000.00	ILS	Annual
Increase in accrued liabilities and other payables	`AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables`	$99.00K	USD	Annual
Increase in contract liabilities (including long term contract liabilities)	`IncreaseInContractLiabilitiesIncludingLongTermContractLiabilities`	$1.95M	USD	Annual
Increase in contract liabilities (including long term contract liabilities)	`IncreaseInContractLiabilitiesIncludingLongTermContractLiabilities`	7.31M	ILS	Annual
Increase (decrease) in royalties to the IIA	`AdjustmentsForIncreaseDecreaseInOtherLiabilities`	$-5.00K	USD	Annual
Increase (decrease) in royalties to the IIA	`AdjustmentsForIncreaseDecreaseInOtherLiabilities`	2.18M	ILS	Annual
Increase (decrease) in royalties to the IIA	`AdjustmentsForIncreaseDecreaseInOtherLiabilities`	-978,000.00	ILS	Annual
Increase (decrease) in royalties to the IIA	`AdjustmentsForIncreaseDecreaseInOtherLiabilities`	-18,000.00	ILS	Annual
Total changes in operating asset and liability	`AdjustmentsForReconcileProfitLoss`	4.11M	ILS	Annual
Total changes in operating asset and liability	`AdjustmentsForReconcileProfitLoss`	-3.09M	ILS	Annual
Total changes in operating asset and liability	`AdjustmentsForReconcileProfitLoss`	3.94M	ILS	Annual
Total changes in operating asset and liability	`AdjustmentsForReconcileProfitLoss`	$1.10M	USD	Annual
Net cash used in operations	`NetCashUsedInOperationsAdditional`	-17.88M	ILS	Annual
Net cash used in operations	`NetCashUsedInOperationsAdditional`	-19.36M	ILS	Annual
Net cash used in operations	`NetCashUsedInOperationsAdditional`	$-1.25M	USD	Annual
Net cash used in operations	`NetCashUsedInOperationsAdditional`	-4.67M	ILS	Annual
Acquisition of fixed assets against issuance of shares and credit See Note 13(A)(1)(C).	`AcquisitionOfFixedAssetsAgainstIssueOfShares`	-	ILS	Annual
Acquisition of fixed assets against issuance of shares and credit See Note 13(A)(1)(C).	`AcquisitionOfFixedAssetsAgainstIssueOfShares`	-	ILS	Annual
Acquisition of fixed assets against issuance of shares and credit See Note 13(A)(1)(C).	`AcquisitionOfFixedAssetsAgainstIssueOfShares`	1.68M	ILS	Annual
Acquisition of fixed assets against issuance of shares and credit See Note 13(A)(1)(C).	`AcquisitionOfFixedAssetsAgainstIssueOfShares`	-	USD	Annual
Conversion of Debentures to pre-paid warrant	`IssueOfConvertibleInstruments`	$3.39M	USD	Annual
Conversion of Debentures to pre-paid warrant	`IssueOfConvertibleInstruments`	12.71M	ILS	Annual
Conversion of Debentures to pre-paid warrant	`IssueOfConvertibleInstruments`	-	ILS	Annual
Conversion of Debentures to pre-paid warrant	`IssueOfConvertibleInstruments`	-	ILS	Annual
Conversion of pre-paid warrants to ordinary shares	`ConversionOfPrepaidWarrantToOrdinaryShare`	-	ILS	Annual
Conversion of pre-paid warrants to ordinary shares	`ConversionOfPrepaidWarrantToOrdinaryShare`	248,000.00	ILS	Annual
Conversion of pre-paid warrants to ordinary shares	`ConversionOfPrepaidWarrantToOrdinaryShare`	-	ILS	Annual
Conversion of pre-paid warrants to ordinary shares	`ConversionOfPrepaidWarrantToOrdinaryShare`	$66.00K	USD	Annual

Stockholders Equity 35 line items

Line Item	Tag	Value	Unit	Period
Proceeds from issue of shares and options, less issue expenses	`ProceedsFromIssueOfSharesAndOptionsLessIssueExpenses`	1.33M	ILS	Annual
Proceeds from issue of shares and warrants, net of issue expenses	`ProceedsFromIssueOfSharesAndWarrantsNetOfIssueExpenses`	634,000.00	ILS	Annual
Proceeds from issue of shares, net of issue expenses	`ProceedsFromIssueOfSharesWarrantsAndDebenturesNetOfIssueExpenses`	350,000.00	ILS	Annual
Proceeds from issue of shares, net of issue expenses	`ProceedsFromIssueOfSharesWarrantsAndDebenturesNetOfIssueExpenses`	$93.00K	USD	Annual
Balance	`Equity`	9.08M	ILS	Point-in-time
Balance	`Equity`	$2.42M	USD	Point-in-time
Balance	`Equity`	9.78M	ILS	Point-in-time
Balance	`Equity`	$4.78M	USD	Point-in-time
Balance	`Equity`	17.93M	ILS	Point-in-time
Balance	`Equity`	5.16M	ILS	Point-in-time
Comprehensive loss for the year	`ProfitLoss`	-20.88M	ILS	Annual
Comprehensive loss for the year	`ProfitLoss`	-13.89M	ILS	Annual
Comprehensive loss for the year	`ProfitLoss`	$-3.70M	USD	Annual
Comprehensive loss for the year	`ProfitLoss`	-27.89M	ILS	Annual
Share-based compensation to employees and consultants	`IncreaseDecreaseThroughSharebasedPaymentTransactions`	3.64M	ILS	Annual
Share-based compensation to employees and consultants	`IncreaseDecreaseThroughSharebasedPaymentTransactions`	$970.00K	USD	Annual
Share-based compensation to employees and consultants	`IncreaseDecreaseThroughSharebasedPaymentTransactions`	3.57M	ILS	Annual
Share-based compensation to employees and consultants	`IncreaseDecreaseThroughSharebasedPaymentTransactions`	4.97M	ILS	Annual
Proceeds from issuance of shares and options, less issuance expenses	`ProceedsFromIssueOfSharesAndOptions`	18.50M	ILS	Annual
Proceeds from issuance of shares and warrants, net of issuance expenses	`ProceedsFromIssueOfSharesAndWarrants`	16.21M	ILS	Annual
Issuance of shares, See Note 13(A)(1)(D)	`IncreaseDecreaseThroughExerciseOfOptions`	1.20M	ILS	Annual
Exercise of warrants into shares	`IncreaseDecreaseThroughExerciseOfWarrantsEquity`	3.62M	ILS	Annual
Conversion of Debentures to Prepaid warrants	`ConversionOfDebenturesToPrepaidWarrants`	$3.39M	USD	Annual
Conversion of Debentures to Prepaid warrants	`ConversionOfDebenturesToPrepaidWarrants`	12.71M	ILS	Annual
Proceeds from issuance of shares, net of issuance expenses	`ShareIssueRelatedCost`	404,000.00	ILS	Point-in-time
Proceeds from issuance of shares, net of issuance expenses	`ShareIssueRelatedCost`	643,000.00	ILS	Point-in-time
Proceeds from issuance of shares, net of issuance expenses	`ShareIssueRelatedCost`	6.38M	ILS	Annual
Proceeds from issuance of shares, net of issuance expenses	`ShareIssueRelatedCost`	$1.70M	USD	Annual
Proceeds from issuance of shares, net of issuance expenses	`ShareIssueRelatedCost`	684,000.00	ILS	Point-in-time
Balance	`Equity`	17.93M	ILS	Point-in-time
Balance	`Equity`	9.08M	ILS	Point-in-time
Balance	`Equity`	$2.42M	USD	Point-in-time
Balance	`Equity`	9.78M	ILS	Point-in-time
Balance	`Equity`	$4.78M	USD	Point-in-time
Balance	`Equity`	5.16M	ILS	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.